Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
Open Access
- 1 January 1983
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 36 (1) , 24-29
- https://doi.org/10.1136/jcp.36.1.24
Abstract
Three cases of acute renal toxicity in patients receiving long-term therapy with mitomycin C and 5-fluorouracil are reported. Two of the patients (1 and 3) are from a multicentre trial of adjuvant chemotherapy for gastric carcinoma. All three cases showed extensive fibrin deposition in the kidneys and lungs, the appearances of the renal lesions being similar to those seen in the haemolytic-uraemic syndrome. Two of the three cases had received blood transfusions, and attention is drawn to the possibility that mitomycin C may sensitise the kidneys to minor mismatches. With the increasing use of these antimitotic agents, great vigilance should be exercised with regard to renal function and haemolytic status.This publication has 9 references indexed in Scilit:
- Renal disease after mitomycin c therapyCancer, 1981
- INTRAVASCULAR HÆMOLYSIS AND RENAL IMPAIRMENT AFTER BLOOD TRANSFUSION IN TWO PATIENTS ON LONG-TERM 5-FLUOROURACIL AND MITOMYCIN-CThe Lancet, 1980
- Interstitial fibrosis in a patient treated with 5-fluorouracil and mitomycin C.BMJ, 1979
- Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin CCancer, 1979
- Interstitial lung disease in a patient treated with 5-fluorouracil and mitomycin C.BMJ, 1978
- Renal toxicity in man treated with mitomycin CCancer, 1971
- Microangiopathic Haemolytic Anaemia and Mucin‐forming AdenocarcinomaBritish Journal of Haematology, 1970
- Microangiopathic Hemolytic Anemia in Carcinoma of the StomachGastroenterology, 1967